{"id":3414,"date":"2025-06-28T13:34:10","date_gmt":"2025-06-28T11:34:10","guid":{"rendered":"http:\/\/redi-group.local\/medical-technology-pharma\/"},"modified":"2026-06-18T21:38:42","modified_gmt":"2026-06-18T19:38:42","slug":"medical-technology-pharma","status":"publish","type":"page","link":"https:\/\/redi-group.com\/cs\/odvetvi\/medical-technology-pharma\/","title":{"rendered":"Zdravotnick\u00e1 technika a farmaceutick\u00fd pr\u016fmysl"},"content":{"rendered":"\n
\n
\n \n \n

\n Kde inovace zachra\u0148uj\u00ed \u017eivoty
a kvalita nen\u00ed p\u0159edm\u011btem vyjedn\u00e1v\u00e1n\u00ed. <\/h1>\n \n \n
\n \n
\n
\n

V oblasti zdravotnick\u00e9 techniky a farmaceutick\u00e9ho pr\u016fmyslu je p\u0159esnost \u017eivotn\u011b d\u016fle\u017eit\u00e1. Regula\u010dn\u00ed po\u017eadavky, technologick\u00fd v\u00fdvoj a tlak na inovace vy\u017eaduj\u00ed trvale stabiln\u00ed, zdokumentovan\u00e9 a auditovateln\u00e9 procesy. Skupina redi-Group podporuje v\u00fdrobce a dodavatele technick\u00fdmi slu\u017ebami v oblasti kvality v r\u00e1mci cel\u00e9ho hodnotov\u00e9ho \u0159et\u011bzce, od v\u00fdroby p\u0159es anal\u00fdzu a\u017e po optimalizaci proces\u016f. A\u0165 u\u017e na n\u00e1rodn\u00ed nebo mezin\u00e1rodn\u00ed \u00farovni, kr\u00e1tkodob\u011b \u010di dlouhodob\u011b \u2013 dod\u00e1v\u00e1me kvalitu, kter\u00e1 spl\u0148uje to, co slibuje. <\/strong><\/span><\/p>\n <\/div>\n <\/div>\n \n \n

\n \n
\n \"\" \n <\/div> <\/div>\n <\/div>\n \n <\/div>\n <\/section>\n
\n
\n \n

\n Jak\u00e1 je va\u0161e v\u00fdzva v oblasti kvality<\/span>? <\/h2>\n \n \n \n
\n
\n \n
\n
\n
\n
\n Strategie \/ Koncepce <\/div>\n <\/div>\n
\n
\n V\u00fdvoj <\/div>\n <\/div>\n
\n
\n Zah\u00e1jen\u00ed <\/div>\n <\/div>\n
\n
\n S\u00e9rie <\/div>\n <\/div>\n
\n
\n Poprodejn\u00ed slu\u017eby <\/div>\n <\/div>\n <\/div>\n <\/div>\n\n \n
\n
\n \n Kontrola, t\u0159\u00edd\u011bn\u00ed a dodate\u010dn\u00e9 \u00fapravy <\/a>\n <\/div>\n
\n \n P\u0159eozna\u010dov\u00e1n\u00ed a bleskov\u00e9 akce <\/a>\n <\/div>\n
\n \n Kontroly p\u0159\u00edjmu a v\u00fddeje zbo\u017e\u00ed <\/a>\n <\/div>\n
\n \n Podpora v\u00fdroby a \u0159\u00edzen\u00ed spou\u0161t\u011bn\u00ed v\u00fdroby <\/a>\n <\/div>\n
\n \n M\u011b\u0159ic\u00ed technika a zkou\u0161en\u00ed materi\u00e1l\u016f <\/a>\n <\/div>\n
\n \n \u0158\u00edzen\u00ed reklamac\u00ed a rezidentn\u00ed in\u017een\u00fdr <\/a>\n <\/div>\n
\n \n Kontrola kvality pomoc\u00ed kamery s um\u011blou inteligenc\u00ed <\/a>\n <\/div>\n
\n \n Audity a rezidentn\u00ed in\u017een\u00fdr <\/a>\n <\/div>\n
\n \n APQP a pl\u00e1nov\u00e1n\u00ed kvality v p\u0159edstihu <\/a>\n <\/div>\n
\n \n \u0158\u00edzen\u00ed dodavatel\u016f a jejich kvalifikace <\/a>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n \n <\/div>\n <\/section>\n
\n
\n
\n
\n \n

\n Kvalita nevznik\u00e1 v zasedac\u00ed m\u00edstnosti \u2013 vznik\u00e1 p\u0159i realizaci. <\/h2>\n \n
\n Va\u0161e kvalita. Na\u0161e motivace. <\/div>\n <\/div>\n\n
\n
\n \n\n VYZV\u011aTE N\u00c1S<\/span>\n \"\"\n\n <\/a> <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n
\n
\n \n
\n

\n S\u00e1zejte na profesion\u00e1ln\u00ed kontroly kvality, kter\u00e9 spl\u0148uj\u00ed nejvy\u0161\u0161\u00ed standardy a zaru\u010duj\u00ed plynul\u00fd pr\u016fb\u011bh v\u00fdroby. Kontaktujte n\u00e1s a domluvte si individu\u00e1ln\u00ed konzultaci!<\/span> <\/p>\n <\/div>\n \n <\/div>\n <\/section>\n

\n \n \n
\n
\n \n
\n

Technick\u00e9 zaji\u0161t\u011bn\u00ed kvality pro odv\u011btv\u00ed, kter\u00e9 ka\u017ed\u00fd den mysl\u00ed dop\u0159edu.<\/span><\/h2>\n <\/div>\n\n <\/div>\n <\/div>\n \n <\/section>\n
\n
\n \n
\n \n \n
\n
\n

Skupina redi-Group podporuje odv\u011btv\u00ed zdravotnick\u00e9 techniky a farmaceutick\u00fd pr\u016fmysl prost\u0159ednictv\u00edm technick\u00fdch slu\u017eeb \u0161it\u00fdch na m\u00edru, kter\u00e9 jsou speci\u00e1ln\u011b p\u0159izp\u016fsobeny po\u017eadavk\u016fm citliv\u00fdch a p\u0159\u00edsn\u011b regulovan\u00fdch produkt\u016f. Na\u0161i odborn\u00edci v\u00e1m poskytnou fundovanou podporu p\u0159\u00edmo ve v\u00fdrob\u011b p\u0159i spou\u0161t\u011bn\u00ed proces\u016f, optimalizaci v\u00fdroby i v p\u0159\u00edpad\u011b \u00fazk\u00fdch m\u00edst. <\/p>\n <\/div>\n <\/div>\n \n \n

\n
\n \n
\n \"\" \n <\/div> <\/figure>\n <\/div>\n \n <\/div>\n \n <\/div>\n <\/section>\n
\n
\n \n
\n \n \n
\n
\n \n
\n \"redi-Group \n <\/div> <\/figure>\n <\/div>\n \n \n
\n
\n

Prov\u00e1d\u00edme komplexn\u00ed vizu\u00e1ln\u00ed a m\u011b\u0159ic\u00ed kontroly kvality, nab\u00edz\u00edme strukturovan\u00e9 anal\u00fdzy chyb a zaji\u0161\u0165ujeme spr\u00e1vu reklamac\u00ed zalo\u017eenou na datech. Krom\u011b toho pom\u00e1h\u00e1me s p\u0159\u00edpravou na audity a prov\u011b\u0159ujeme zm\u011bny v procesu schvalov\u00e1n\u00ed. Prost\u0159ednictv\u00edm praktick\u00fdch \u0161kolen\u00ed posilujeme v\u00e1\u0161 t\u00fdm tak, aby spl\u0148oval vysok\u00e9 standardy kvality v tomto odv\u011btv\u00ed. Na\u0161e slu\u017eby jsou flexibiln\u011b \u0161k\u00e1lovateln\u00e9 \u2013 od jednotliv\u00e9 kontroly a\u017e po integraci do s\u00e9riov\u00fdch proces\u016f. P\u016fsob\u00edme na mezin\u00e1rodn\u00ed \u00farovni a zaji\u0161\u0165ujeme kvalitu p\u0159esn\u011b tam, kde na n\u00ed z\u00e1le\u017e\u00ed: na v\u00fdrobn\u00ed lince nebo v laborato\u0159i. <\/p>\n <\/div>\n <\/div>\n \n <\/div>\n \n <\/div>\n <\/section>\n

\n \n \n
\n
\n \n
\n

Post\u0159ehy z na\u0161\u00ed praxe<\/span><\/h2>\n <\/div>\n\n <\/div>\n <\/div>\n \n <\/section>\n
\n
\n \n \n
\n
\n
\n \n
\n <\/a>\n
\n \"Americk\u00fd\n <\/div>\n \n
\n

\n Americk\u00fd dodavatel dos\u00e1hl 100% dodavatelsk\u00e9 schopnosti <\/h3>\n\n
\n \n \n CASE STUDY<\/span>\n\n \"\"\n\n <\/a>\n <\/div>\n <\/div>\n<\/article>\n <\/div>\n
\n \n
\n <\/a>\n
\n \"Efektivn\u00ed\n <\/div>\n \n
\n

\n Efektivn\u00ed \u0159\u00edzen\u00ed projekt\u016f pro v\u00fdrobce origin\u00e1ln\u00edho vybaven\u00ed (OEM) <\/h3>\n\n
\n \n \n CASE STUDY<\/span>\n\n \"\"\n\n <\/a>\n <\/div>\n <\/div>\n<\/article>\n <\/div>\n
\n \n
\n <\/a>\n
\n \"97\n <\/div>\n \n
\n

\n 97 % \u00fasp\u011b\u0161nost KPI p\u0159i kontrole p\u0159\u00edjmu zbo\u017e\u00ed od OEM <\/h3>\n\n
\n \n \n CASE STUDY<\/span>\n\n \"\"\n\n <\/a>\n <\/div>\n <\/div>\n<\/article>\n <\/div>\n <\/div>\n <\/div>\n \n <\/div>\n <\/section>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":4842,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-3414","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/redi-group.com\/cs\/wp-json\/wp\/v2\/pages\/3414","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/redi-group.com\/cs\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/redi-group.com\/cs\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/redi-group.com\/cs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/redi-group.com\/cs\/wp-json\/wp\/v2\/comments?post=3414"}],"version-history":[{"count":4,"href":"https:\/\/redi-group.com\/cs\/wp-json\/wp\/v2\/pages\/3414\/revisions"}],"predecessor-version":[{"id":4851,"href":"https:\/\/redi-group.com\/cs\/wp-json\/wp\/v2\/pages\/3414\/revisions\/4851"}],"up":[{"embeddable":true,"href":"https:\/\/redi-group.com\/cs\/wp-json\/wp\/v2\/pages\/4842"}],"wp:attachment":[{"href":"https:\/\/redi-group.com\/cs\/wp-json\/wp\/v2\/media?parent=3414"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}